The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Achilles Therapeutics plc(NASDAQ:ACHL) 
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-sma...
Achilles Therapeutics plc Number of Twitter Followers
Achilles Therapeutics plc Days Payable Outstanding ttm (DPO)
Achilles Therapeutics plc Days Inventory Outstanding ttm (DIO)
Achilles Therapeutics plc Op Cashflow Per Share ttm
Achilles Therapeutics plc Free Cashflow Per Share ttm
Achilles Therapeutics plc Cash Per Share ttm
Achilles Therapeutics plc (GAAP) P/E ratio ttm
Achilles Therapeutics plc P/B ratio ttm
No extra charts and metrics for this ticker.